Navigation Links
China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
Date:8/26/2010

therapy combats tumors in patients with hepatocellular carcinoma (HCC), commonly known as primary liver cancer, who cannot be treated with surgery, and are awaiting an organ transplant.

As the exclusive distributor in the Greater China Region, Singapore, Malaysia and Bangladesh of this new form of liver cancer treatment, PharmaHub believes that the therapy offers a solution to the problem of malignant liver cancer in Southeast Asia where approximately three-quarters of the cases of liver cancer worldwide are found. China, alone, has the highest number of liver cancer patients worldwide, approximately one-half of the world HCC population, with more than 350,000 new cases diagnosed each year, a number that is expected by Management to continue to rise in the coming years. As projected by IMS Health, China will become the world's third-largest pharmaceutical market by 2011, growing by more than 20% annually. Oncology is among the top five therapy classes in China, which recorded a staggering 27% compound annual growth rate ("CAGR") from 2005-2009 and is poised to achieve similar gains through 2015.

Richard Lui, CEO of PharmaHub stated, "We are thrilled with this opportunity to take a leadership role in introducing this type of radioembolization treatment for inoperable liver cancer in China and Southeast Asia. This therapy is a pioneering alternative to surgery, chemotherapy and other radiation therapies in current usage. Overall, the treatment can cause fewer and milder side effects than other current treatments and offers the convenience of outpatient therapy at a significantly lower price than the more conventional treatments."

"PharmaHub plans to immediately set up clinical studies in China to test wider applications of the medical technology, not only for liver but other cancers, then move to commercialization of the procedure in a cost-effective and reliable manner throughout China," stated Mr. Lui.   "We also foresee the potential medic
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CHAPEL HILL, N.C. , June 18, 2013 /PRNewswire/ ... and more difficult for Medical Education groups at large ... practitioners on the safe and effective use of their ... within the pharma industry, it is crucial that these ... of reaching healthcare professionals. To address the ...
(Date:6/18/2013)...  Cataracts are the leading cause of blindness in ... aging is the leading cause of eye diseases such ... 22 million Americans age 40 and older have cataracts, ... that number will increase over 30 million.  In a ... and computers, the demographic of ages 40 plus works ...
(Date:6/18/2013)... -- In a letter to authorities at her hospital, orthopaedic surgeon ... View, Iowa , writes that a policy of forcing ... scientifically justified nor ethically sound. Her letter is ... of the Journal of American Physicians and Surgeons. ... average of 36,000 patients per year die in U.S. hospitals ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2
(Date:6/18/2013)... June 18, 2013 Exposed Skin Care has ... of acne suffers of all ages finally achieve the clear, ... treatment products, this new acne clearing system combines the power ... prevent new acne from forming. , After a ... these products are some of the most effective available on ...
(Date:6/18/2013)... (PRWEB) June 19, 2013 Parker Waichman ... rights of victims injured by dangerous drugs and medical ... Arizona woman who alleges that she was injured ... on May 30th in the U.S. District Court for ... 2:13-cv-12677) in the multidistrict litigation entitled In Re: American ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... CONCACAF tickets for the tournament which gets underway in ... additional savings on any CONCACAF ticket order. , ... nook and cranny of the globe.    In fact, the hype of ... America. Its popularity also trickled down the veins of ...
(Date:6/18/2013)... 2013 SEATTLE, WA—A Washington state resident ... Oregon, claiming he fell ill with a hepatitis A ... seed blend. The complaint was filed in Snohomish ... the Seattle-based law firm that has filed 14 ... the complaint, Brian Brothers consumed “Townsend Farms Organic Antioxidant ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Parker ... protecting the rights of victims injured by defective medical ... review of Medtronic’s Infuse bone graft products are now ... a medical journal, the two studies serve up two ... effectiveness” when comparing Infuse and the traditional bone graft; ...
Breaking Medicine News(10 mins):Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3
... study of targeted educational initiatives between the clinical staff ... their Partners program suggest that educational interventions by academic ... patients at community hospitals. The study, to be ... Society of Clinical Oncology, looked specifically at the number ...
... knowledge could guide important treatment decisions, experts say , , ... test aimed at predicting colon cancer recurrence may help ... more targeted therapy choices, scientists say. , The Oncotype ... cancer were more likely to have a recurrence and ...
... a predictor of overall survival benefit with EGFRI treatmentBROOMFIELD, ... proteomic test currently used for patients with advanced stage ... Chung, MD, Assistant Professor of Medicine at Vanderbilt ... Annual Meeting of the American Society of Clinical Oncology ...
... Stars Visit Children,s Memorial Hospital in Chicago , ... ... competitors Dave Menne and Kevin Knabjian took time away from ... Chicago for a different kind of fight; the fight ...
... 14 /PRNewswire-Asia/ -- Gold Rock Resources Inc. (OTC,Bulletin Board: ... related to the hollow fiber membrane materials, application and,manufacturing ... to:,RainEarth Inc. to better reflect its business. The Company ... has launched a new English web site. The,URL of ...
... In response to the FDA,s approval of Prevacid OTC(R) ... statement: (Photo: http://www.newscom.com/cgi-bin/prnh//NY17325 ... recommended over-the-counter heartburn remedy in the U.S.," said Tim ... America. "Procter & Gamble built the OTC PPI market ...
Cached Medicine News:Health News:Educational initiatives improve quality of care delivery 2Health News:Gene Screen May Predict Colon Cancer's Return 2Health News:Gene Screen May Predict Colon Cancer's Return 3Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3Health News:Mixed Martial Arts Athletes Fight For Children 2Health News:Mixed Martial Arts Athletes Fight For Children 3Health News:Gold Rock Changed Name to RainEarth Inc. and Launches New English Web Site 2Health News:P&G Response to FDA Approval of Prevacid OTC(R) 24HR 2
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... The PowerLab/16SP is a high-performance recording unit ... science research applications that require up to ... and isolated tissue studies. The unit is ... to 200 000 samples per second continuously ...
Three Figure Worth Type Test, this test is used for determining diplopia, suppression or fusion in children. Sturdy chrome flashlight comes with red/green glasses. Requires 3 D batteries which are no...
Medicine Products: